| Join us on Wednesday, October 22, for a full day of discussions and presentations focused on ethical, actionable, and practical solutions to today’s global clinical research challenges. Engage with regulators, industry leaders, patient advocates, and research experts to gain insights, shape the conversation, and forge connections that drive real-world impact. While we have hit capacity for in-person attendance, virtual attendance is still available! The Symposium is free and open to all registrants.
We are pleased to announce our keynote speaker: John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), which represents biotech companies, industry leaders, and state associations across the U.S. and in more than 35 countries worldwide. John’s decades of experience and deep passion for the field have made him a leading advocate for policies that empower innovation, enable entrepreneurship, and put people and patients first.
Agenda highlights include:
· Clinical Trial Reform: The Need for Change and Progress · Rethinking Informed Consent with Artificial Intelligence: Opportunities and Challenges · Cell and Gene Therapies Long-Term Follow-Up: Key Deliverables and the Path Forward · Reinventing Informed Consent: Emerging from the Chrysalis
On Thursday morning, October 23, the MRCT Center will co-host a joint meeting with the Vivli annual meeting. Sessions will focus on the journey from data contribution to impact in clinical trial methodology, oncology, and Type 1 diabetes, including the latest in sharing imaging data and applying new DOJ rulings on sharing data with countries of concern. This event is also complimentary and open to all Symposium registrants.
|
